The H-2Kb gene equipped with a minimal promoter (5' deletion up to -61) was fully expressed in transfected fibroblasts, but inactive in transfected embryonal carcinoma cells. A strong transcriptional regulatory element (H2DRE) was identified when a fragment spanning the second exon and second intron was used to activate transient expression of the reporter chloramphenicol acetyltransferase (CAT) gene in mouse Ltk- or NIH3T3 fibroblasts. Its activity was twice that of a construct where the CAT gene was driven by the H-2Kb 5' enhancer region (H2TF1/KBF1 site) and comparable to that of pRSVCAT construct carrying the strong Rous sarcoma virus LTR enhancer. In accord with regulated transcriptional activity of the intact H-2Kb gene, the H2DRE did not activate the CAT expression in P19 mouse embryonal carcinoma cells. The H2DRE did not function as a typical enhancer since its activity was strongly position dependent. Consistent with its anticipated role in transcription regulation, H2DRE displayed more than five target sites for specifically interacting nuclear factors, two of them being present in H-2 positive fibroblasts, but not in H-2 negative teratocarcinoma cells. None of them was cross-competed by sequences of the 5' enhancer. The results of deletion experiments show that H2DRE is the only regulatory region that can activate transcription from the 5' enhancerless H-2Kb gene in mouse L fibroblasts.

Institute of Molecular Genetics Czechoslovak Academy of Sciences Prague

Zobrazit více v PubMed

Nucleic Acids Res. 1986 Apr 11;14(7):2845-61 PubMed

Proc Natl Acad Sci U S A. 1989 Jul;86(14):5247-51 PubMed

EMBO J. 1989 Dec 1;8(12):3793-800 PubMed

Genes Dev. 1989 Sep;3(9):1384-400 PubMed

Nucleic Acids Res. 1989 Jul 11;17(13):5245-57 PubMed

Immunogenetics. 1989;29(4):269-72 PubMed

Mol Cell Biol. 1989 May;9(5):2224-7 PubMed

Annu Rev Cell Biol. 1988;4:127-53 PubMed

Nucleic Acids Res. 1989 Jan 25;17(2):601-15 PubMed

J Exp Med. 1989 Apr 1;169(4):1309-21 PubMed

Science. 1985 Nov 15;230(4727):777-83 PubMed

Proc Natl Acad Sci U S A. 1987 May;84(10):3380-4 PubMed

Science. 1988 Mar 11;239(4845):1302-6 PubMed

EMBO J. 1987 Nov;6(11):3317-24 PubMed

Genet Res. 1988 Apr;51(2):111-9 PubMed

Somat Cell Mol Genet. 1984 Sep;10(5):435-43 PubMed

Cell. 1980 May;20(1):95-105 PubMed

Mol Cell Biol. 1989 Jun;9(6):2588-97 PubMed

Mol Cell Biol. 1988 Aug;8(8):3227-34 PubMed

Immunogenetics. 1985;21(6):601-11 PubMed

Nucleic Acids Res. 1987 Jul 24;15(14):5739-47 PubMed

Nucleic Acids Res. 1988 Mar 25;16(5):1879-902 PubMed

Cell. 1988 Apr 8;53(1):11-24 PubMed

Mol Cell Biol. 1988 Jan;8(1):267-72 PubMed

Mol Cell Biol. 1987 Jul;7(7):2625-30 PubMed

Proc Natl Acad Sci U S A. 1987 Oct;84(20):7056-60 PubMed

Nature. 1987 Dec 17-23;330(6149):660-2 PubMed

Cell. 1986 Jan 31;44(2):261-72 PubMed

Nature. 1986 Aug 21-27;322(6081):743-6 PubMed

Mol Cell Biol. 1984 Sep;4(9):1695-705 PubMed

Proc Natl Acad Sci U S A. 1981 Sep;78(9):5754-8 PubMed

Methods Enzymol. 1980;65(1):499-560 PubMed

Nature. 1980 Nov 13;288(5787):179-81 PubMed

EMBO J. 1983;2(2):245-54 PubMed

Adv Immunol. 1979;27:51-177 PubMed

Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1944-8 PubMed

Immunol Today. 1990 Aug;11(8):286-92 PubMed

Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):937-41 PubMed

EMBO J. 1990 Mar;9(3):833-40 PubMed

Mol Cell Biol. 1991 Aug;11(8):4217-27 PubMed

Crit Rev Immunol. 1990;10(3):235-57 PubMed

Cell. 1990 Sep 7;62(5):1007-18 PubMed

Cell. 1986 Mar 28;44(6):959-68 PubMed

Anal Biochem. 1987 Apr;162(1):156-9 PubMed

Proc Natl Acad Sci U S A. 1985 Apr;82(8):2427-31 PubMed

Cell. 1989 Jul 28;58(2):227-9 PubMed

Mol Cell Biol. 1989 May;9(5):2075-82 PubMed

Anal Biochem. 1983 Jul 1;132(1):6-13 PubMed

Cell. 1984 Apr;36(4):983-92 PubMed

Eur J Biochem. 1980 Jun;107(2):303-14 PubMed

Dev Biol. 1982 Feb;89(2):503-8 PubMed

Transplantation. 1978 Aug;26(2):119-25 PubMed

Curr Top Microbiol Immunol. 1978;81:115-20 PubMed

Anal Biochem. 1976 May 7;72:248-54 PubMed

Immunogenetics. 1990;31(4):245-52 PubMed

Genes Dev. 1990 May;4(5):835-48 PubMed

Mol Cell Biol. 1991 Jul;11(7):3564-72 PubMed

Cell. 1991 Apr 19;65(2):293-304 PubMed

Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3145-9 PubMed

EMBO J. 1991 Jun;10(6):1365-73 PubMed

Mol Cell Biol. 1991 Aug;11(8):4228-34 PubMed

EMBO J. 1990 Jan;9(1):127-35 PubMed

Proc Natl Acad Sci U S A. 1988 Feb;85(3):723-7 PubMed

Proc Natl Acad Sci U S A. 1986 Dec;83(24):9537-41 PubMed

J Exp Med. 1987 Sep 1;166(3):625-36 PubMed

Proc Natl Acad Sci U S A. 1987 Dec;84(24):8864-8 PubMed

Proc Natl Acad Sci U S A. 1987 May;84(10):3400-4 PubMed

Mol Cell Biol. 1987 Dec;7(12):4542-8 PubMed

Mol Cell Biol. 1987 Jan;7(1):305-13 PubMed

Mol Cell Biol. 1985 Jan;5(1):197-203 PubMed

Transplantation. 1974 Jun;17(6):632-4 PubMed

Annu Rev Immunol. 1983;1:529-68 PubMed

Nature. 1982 Mar 18;296(5854):260-2 PubMed

Natl Cancer Inst Monogr. 1982;60:175-80 PubMed

J Mol Appl Genet. 1983;2(1):101-9 PubMed

Proc Natl Acad Sci U S A. 1984 Feb;81(3):649-53 PubMed

Nature. 1983 Oct 27-Nov 2;305(5937):771-5 PubMed

Mol Cell Biol. 1990 Aug;10(8):4100-9 PubMed

EMBO J. 1990 Jan;9(1):233-40 PubMed

A novel type of retinoic acid response element in the second intron of the mouse H2Kb gene is activated by the RAR/RXR heterodimer